Missense mutations or deletion of SCN1A have been shown to lead to loss of sodium current in GABA-mediated inhibitory interneurons, resulting in Dravet syndrome (DS), which often occurs in the first year of life) [79,80]. Here, SCN1A is linked to encephalopathy, progressive, early-onset, with brain edema and/or leukoencephalopathy.